Filing Details

Accession Number:
0001179110-13-002018
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-06 16:27:28
Reporting Period:
2013-02-04
Filing Date:
2013-02-06
Accepted Time:
2013-02-06 16:27:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
203077 St Jude Medical Inc STJ Electromedical & Electrotherapeutic Apparatus (3845) 411276891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1423587 M Denis Gestin One St. Jude Medical Drive
St Paul MN 55117
President, Int'l Division No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-04 37,120 $30.58 42,712 No 4 M Direct
Common Stock Disposition 2013-02-04 37,120 $41.07 5,592 No 4 S Direct
Common Stock Acquisiton 2013-02-05 52,880 $30.58 58,472 No 4 M Direct
Common Stock Disposition 2013-02-05 52,880 $41.49 5,592 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-02-04 37,120 $0.00 90,000 $30.58
Common Stock Stock Option (Right to Buy) Disposition 2013-02-05 52,880 $0.00 52,880 $30.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,880 2009-12-15 2016-12-15 No 4 M Direct
0 2009-12-15 2016-12-15 No 4 M Direct
Footnotes
  1. The price in Column 4 is a weighted average. The prices actually received ranged from $41.03 to $41.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. The price in Column 4 is a weighted average. The prices actually received ranged from $41.42 to $41.5201. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The option shares vested 25% on each of the first four anniversary dates of the date of the grant beginning the date shown and became fully vested on December 15, 2012.